|
|
 |
Avalon works with a team of advisors who have outstanding industry knowledge, extensive technical and scientific expertise and the experience required to evaluate investment opportunities.
Dr. Nick Lydon received his Ph.D. in Biochemistry from the Medical Sciences Institute, University of Dundee, Scotland in 1982. His thesis involved research work on adenylate cyclase and cAMP dependent protein kinase... read more
Court R. Turner joined Avalon Ventures in January 2008, focusing on the formation and strategic operations of the Avalon VIII portfolio companies. Currently, Mr. Turner is the Chief Operating Officer of Carolus Therapeutics, Afraxis, Inc.... read more
Dr. Ben Vollrath is a drug discovery scientist and entrepreneur and joined Avalon Ventures in February 2007 as an Entrepreneur in Residence. His efforts are focused on identifying and developing seed and early-stage investment opportunities.... read more
Dr. Charles Zuker is Professor and Investigator of the Howard Hughes Medical Institute, Departments of Biology and Neurosciences, School of Medicine at the University of California, San Diego... read more
|
|
